IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,034,149 | -34.7% | 790,143 | -15.6% | 0.26% | -28.6% |
| Q4 2022 | $4,645,045 | +3.8% | 936,501 | 0.0% | 0.37% | -2.4% |
| Q3 2022 | $4,476,000 | -1.0% | 936,501 | -6.8% | 0.38% | -0.8% |
| Q2 2022 | $4,521,000 | -58.3% | 1,004,626 | -55.8% | 0.38% | -54.9% |
| Q1 2022 | $10,831,000 | -57.6% | 2,275,409 | -33.9% | 0.85% | -47.9% |
| Q4 2021 | $25,551,000 | +49.5% | 3,443,524 | +14.3% | 1.63% | +53.7% |
| Q3 2021 | $17,086,000 | -2.3% | 3,013,467 | +13.5% | 1.06% | +19.6% |
| Q2 2021 | $17,495,000 | +16.8% | 2,654,838 | +43.5% | 0.89% | -10.8% |
| Q1 2021 | $14,983,000 | – | 1,849,772 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |